A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and radiation therapies.

Typical follow-up care after the HIFU procedure will include PSA testing ... treatment option for early to intermediate-stage prostate cancer, visit the VCU Massey Comprehensive Cancer ...

Prostate cancer is the second most common form of cancer in ... is optimized to meet the patient’s needs. Treatments can include surgery, radiotherapy, ultrasound (HIFU), hormonal therapy and ...

Our strong fourth quarter performance reflects our continued progress in establishing Focal One Robotic HIFU as a mainstream treatment option for the management of prostate cancer,” said Ryan Rhodes, ...

Reports revenue $21.5M, consensus $20.83M. “Our strong fourth quarter performance reflects our continued progress in establishing Focal One ...

Robotic HIFU versus surgery in the management of prostate cancer First patients treated in Phase I/II study evaluating Focal One Robotic HIFU for the treatment of Benign Prostatic Hyperplasia (BPH) ...

Record full-year 2024 HIFU revenue of USD 25.7 million ... outcomes with Focal One ® Robotic HIFU versus surgery in the management of prostate cancer First patients treated in Phase I/II study ...